Advertisement

Indian Journal of Surgery

, Volume 76, Issue 3, pp 217–222 | Cite as

A Systematic Review of Current Understanding and Management of Mastalgia

  • Kamal Kataria
  • Anita Dhar
  • Anurag SrivastavaEmail author
  • Sandeep Kumar
  • Amit Goyal
Review Article

Abstract

Breast pain or mastalgia is the common symptom in the breast. The two most common concerns of patients presenting with mastalgia are: the fear that breast pain is a symptom of breast cancer and the presence of severe pain that affects a woman’s quality of life. Breast pain requires thorough assessment and should be investigated in the same manner as any other breast symptom. We conducted a systematic review of treatment for breast pain. We searched various reviews, randomized controlled trial, and observational studies over Pubmed and Medline via internet. Searches were carried out on MEDLINE (1950–present), EMBASE (1980–present), and CINAHL (1981–present) using the NHS Evidence Healthcare Databases Advanced Search interface. A further search was also carried out on Cochrane Database of Systematic Reviews (issue 12 of 12, Dec 2011) and Central Register of Controlled Trials (issue 4 of 4, Oct 2011). If no abnormality is found in the breast on assessment, then a combination of reassurance, breast support brassiere, and topical NSAID gel massage are usually effective. Antiestrogen (centchroman/tamoxifen) therapy for 3 to 6 months is the second-line treatment of choice. Danazol may be used in resistant cases. Gamma-linolenic acid or evening primrose oil though commonly prescribed is not effective.

Keywords

Mastalgia Cyclical mastalgia Noncyclical mastalgia Centchroman Danazol Diclofenac gel 

Notes

Conflict of Interest

None

References

  1. 1.
    Barton MB, Elmore JG, Fletcher SW (1999) breast symptom among women enrolled in a health maintenance organization: frequency, evaluation and outcome. Ann Intern Med 130:651–657PubMedGoogle Scholar
  2. 2.
    Ader DN, South-Paul J, Adera T, Deuster PA (2001) Cyclical mastalgia: prevalence and associated health behavioral factors. J Psychosom Obstet Gynaecol 22:71–76PubMedCrossRefGoogle Scholar
  3. 3.
    Mansel RE, Webster DJT, Sweetland HM (2009) Breast pain and nodularity. In: Mansel RE, Webster DJT, Sweetland HM (eds) Benign disorders and disease of the breast, 3rd edn. Saunders Elsevier, Philadelphia, pp 107–138Google Scholar
  4. 4.
    Kumar S, Rai R, Das V, Dwivedi V, Kumar S, GG A (2010) Visual analogue scale for assessing breast nodularity in non discrete lumpy breasts: the Lucknow Cardiff breast nodularity scale. The Breast 19:238–242PubMedCrossRefGoogle Scholar
  5. 5.
    Wisbey JR, Kumar S, Mansel RE, Preece PE, Pye JK, Hughes LE (1983) Natural history of breast pain. Lancet ii:672–674CrossRefGoogle Scholar
  6. 6.
    Smith RL, Pruthi S, Fitzpatrick LA (2004) Evaluation and management of breast pain. Mayo Clin Proc 79(3):353–372PubMedCrossRefGoogle Scholar
  7. 7.
    Malarkey WB, Schrooeder LL, Stevens VC, James AG, Lanese RR (1977) Twenty four hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res 37:4655–4659PubMedGoogle Scholar
  8. 8.
    Sitruk-Ware R, Sterkers N, Mauvais-Jarvis P (1979) Benign breast disease.1: hormonal investigation. Obstet Gynecol 53:457–460PubMedGoogle Scholar
  9. 9.
    Peters F, Pickcardt CR, Zimmerman G (1981) PRL, TSH and thyroid hormones in benign breast disease. Klin Wochenschr 59:403–407PubMedCrossRefGoogle Scholar
  10. 10.
    Kumar S, Mansel RE, Scanlon MF, Hughes LE (1984) Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotropin releasing hormone stimulation in cyclical mastalgia. Br J Surg 71:870–873PubMedCrossRefGoogle Scholar
  11. 11.
    Preece PE, Richards AR, Owen GM (1975) Mastalgia and total body water. Br Med J 4:498–500PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Preece PE, Mansel R, Hughes LE (1978) Mastalgia: psychoneurosis or organic disease? Br Med J I:9–30Google Scholar
  13. 13.
    Minton JP, Foeking MK, Webster DJT (1979) Response of fibrocystic disease to caffeine withdrawal and correlation with cyclic nucleotides with breast disease. Am J Obstet Gynaecol 135:157Google Scholar
  14. 14.
    Ernster VL, Mason L, Goodson WH (1982) Effects of caffeine free diet on benign breast disease: a randomized trial. Surgery 91:263–267PubMedGoogle Scholar
  15. 15.
    Peters F, Diemer P, Mecks O (2003) Severity of mastalgia in relation to milk duct dilatation. Obstet Gynaecol 101(1):54–60CrossRefGoogle Scholar
  16. 16.
    Wewers ME, Lowe NK (1990) A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Heal 13:227–236CrossRefGoogle Scholar
  17. 17.
    Hadi MS (2000) Sports brassiere: is it a solution for mastalgia? Breast J 6:407–409PubMedCrossRefGoogle Scholar
  18. 18.
    Rosolowich V, Saettler E, Szuck B (2006) Mastalgia. J Obstet Gynaecol Can 28(1):49–71PubMedGoogle Scholar
  19. 19.
    Shurks M, Glynn RJ, Rist PM, Tzourio C, Kurth T (2010) Effects of vitamin E on stroke subtypes: meta-analysis of randomized controlled trials. BMJ 341:c5702–1315. doi: 10.1136/c5702 CrossRefGoogle Scholar
  20. 20.
    Blommers J, de Lange-De Klerk ES, Kuik DJ (2002) Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. Am J Obstet Gynecol 187:1389–1394PubMedCrossRefGoogle Scholar
  21. 21.
    Pashby NL, Mansel RE, Hughes LE (1981) A clinical trial of evening primrose oil in mastalgia. Br J Surg 68:801CrossRefGoogle Scholar
  22. 22.
    Srivastava A, Mansel RE, Arvinda N (2007) Evidence-based management of mastalgia: a meta-analysis of randomized trials. Breast 16(5):503–512PubMedCrossRefGoogle Scholar
  23. 23.
    Colak T, Ipek T, Kanik A (2003) Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 196:525–530PubMedCrossRefGoogle Scholar
  24. 24.
    Coney P, Washenik K, Langley RG, Harrison DD (2001) Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 63:297–302PubMedCrossRefGoogle Scholar
  25. 25.
    Uzan S, Denis C, Pomi V, Varin C (1992) Double-blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease. Eur J Obstet Gynecol Reprod Biol 43:219–227PubMedCrossRefGoogle Scholar
  26. 26.
    Colin C, Gaspard U, Lambotte R (1978) Relationship of mastodynia with its endocrine environment and treatment in a double blind trial with lynestrenol. Arch Gynakol 225:7–13PubMedCrossRefGoogle Scholar
  27. 27.
    Fentiman IS, Caleffi M, Brame K (1986) Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 8376:287–288CrossRefGoogle Scholar
  28. 28.
    Tejwani P, Srivastava A, Nerkar H, Dhar A, Hari S, Thulkar S, Chumber S, Kumar S (2011) Centchroman regresses mastalgia: a randomized comparison with danazol. Indian J Surg 73(3):199–205PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Srivastava A, Dhar A (2007) Role of centchroman in regression of mastalgia and fibroadenoma. Word J Surg 31:1178–1184Google Scholar
  30. 30.
    Kamboj VP, Ray S, Dhawan BN (1992) Centchroman. Drugs Today 28:227–232Google Scholar
  31. 31.
    Greenblatt RB, Dmowske WP, Mhesh VB (1971) Clinical studies with an antigonadotrophin—danazol. Fertil Steril 22:102–112PubMedGoogle Scholar
  32. 32.
    Shukla HS, Kumar S (1989) Benign breast disorders in nonwestern populations: Part II—benign breast disorders in India. World J Surg 13(6):746–749PubMedCrossRefGoogle Scholar
  33. 33.
    Asch RH, Greenblatt RB (1971) The use of an impeded androgen danazol in the management of benign breast disorders. Am J Obstet Gynecol 127:130–134Google Scholar
  34. 34.
    Mansel RE, Wisbey JR, Hughes LE (1982) Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease. Lancet 1(8278):928–931PubMedCrossRefGoogle Scholar
  35. 35.
    Goyal A, Mansel RE (2005) A randomized multicenter studies of gamolenic acid (Efamast) with and without antioxidant vitamins and minerals in the management of mastalgia. Breast J 11:41–47PubMedCrossRefGoogle Scholar
  36. 36.
    Lopez-Rosales C, Aguilar-Guerrero JA, Garcia-Moreno L (1996) Treatment of premenstrual tension syndrome with lisuride maleate. Gynecol Obstet Mex 64:556–560Google Scholar
  37. 37.
    Mansel RE, Goyal A, Preece P, Leinster S, Maddox PR (2004) European randomized multicenter study of goserelin (Zoladex) in the management of mastalgia. Am J Obstet Gynecol 191(6):1942–1949PubMedCrossRefGoogle Scholar
  38. 38.
    Steinbrunn BS, Zera RT, Rodriguez JL (1997) Mastalgia: tailoring treatment to type of breast pain. Postgrad Med 102(5):183–184, 187-9,193-4PubMedGoogle Scholar
  39. 39.
    Gateley CA, Mansel RE (1991) Management of the painful and nodular breast. Br Med Bull 47(2):284–294PubMedGoogle Scholar
  40. 40.
    Davies EL, Cochrane RA, Stansfield K, Mansel RE (1999) Is there a role for surgery in the treatment of mastalgia? Breast 8(5):285–288PubMedCrossRefGoogle Scholar

Copyright information

© Association of Surgeons of India 2013

Authors and Affiliations

  • Kamal Kataria
    • 1
  • Anita Dhar
    • 1
  • Anurag Srivastava
    • 1
    Email author
  • Sandeep Kumar
    • 2
  • Amit Goyal
    • 3
  1. 1.Department of Surgical DisciplinesAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Department of Surgical DisciplinesAll India Institute of Medical SciencesBhopalIndia
  3. 3.Derbyshire Breast UnitDerbyshireUK

Personalised recommendations